FEATURED COMPANIES
- Becton
- Cellnovo Limited
- CeQur SA
- Debiotech S.A.
- Dickinson and Company
- Eoflow Co. Ltd
Global Insulin Patch Pumps Market to Reach $1.6 Billion by 2027
Amid the COVID-19 crisis, the global market for Insulin Patch Pumps estimated at US$829.6 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 9.5% over the analysis period 2020-2027. Basal & Bolus, one of the segments analyzed in the report, is projected to record a 9.3% CAGR and reach US$850.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Basal segment is readjusted to a revised 10.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $224.3 Million, While China is Forecast to Grow at 12.6% CAGR
The Insulin Patch Pumps market in the U.S. is estimated at US$224.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$327.6 Million by the year 2027 trailing a CAGR of 12.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 8.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.
Bolus Segment to Record 8.5% CAGR
In the global Bolus segment, USA, Canada, Japan, China and Europe will drive the 7.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$123.4 Million in the year 2020 will reach a projected size of US$210.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$223.2 Million by the year 2027, while Latin America will expand at a 9.9% CAGR through the analysis period.
Select Competitors (Total 42 Featured):
Amid the COVID-19 crisis, the global market for Insulin Patch Pumps estimated at US$829.6 Million in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 9.5% over the analysis period 2020-2027. Basal & Bolus, one of the segments analyzed in the report, is projected to record a 9.3% CAGR and reach US$850.8 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Basal segment is readjusted to a revised 10.6% CAGR for the next 7-year period.
The U.S. Market is Estimated at $224.3 Million, While China is Forecast to Grow at 12.6% CAGR
The Insulin Patch Pumps market in the U.S. is estimated at US$224.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$327.6 Million by the year 2027 trailing a CAGR of 12.5% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.5% and 8.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.4% CAGR.
Bolus Segment to Record 8.5% CAGR
In the global Bolus segment, USA, Canada, Japan, China and Europe will drive the 7.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$123.4 Million in the year 2020 will reach a projected size of US$210.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$223.2 Million by the year 2027, while Latin America will expand at a 9.9% CAGR through the analysis period.
Select Competitors (Total 42 Featured):
- Becton
- Cellnovo Limited
- CeQur SA
- Debiotech S.A.
- Dickinson and Company
- Eoflow Co. Ltd
- Insulet Corporation
- Johnson & Johnson
- Unilife Corporation
- Valeritas Holdings Inc
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Becton
- Cellnovo Limited
- CeQur SA
- Debiotech S.A.
- Dickinson and Company
- Eoflow Co. Ltd
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
- UNITED STATES
- CANADA
- JAPAN
- CHINA
- EUROPE
- FRANCE
- GERMANY
- ITALY
- UNITED KINGDOM
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA-PACIFIC
- AUSTRALIA
- INDIA
- SOUTH KOREA
- REST OF ASIA-PACIFIC
- LATIN AMERICA
- ARGENTINA
- BRAZIL
- MEXICO
- REST OF LATIN AMERICA
- MIDDLE EAST
- IRAN
- ISRAEL
- SAUDI ARABIA
- UNITED ARAB EMIRATES
- REST OF MIDDLE EAST
- AFRICA
- Total Companies Profiled: 42
Note: Product cover images may vary from those shown
- Becton
- Cellnovo Limited
- CeQur SA
- Debiotech S.A.
- Dickinson and Company
- Eoflow Co. Ltd
- Insulet Corporation
- Johnson & Johnson
- Unilife Corporation
- Valeritas Holdings Inc
Note: Product cover images may vary from those shown
